Arda Therapeutics: Market Research Report
Company Overview
- Name: Arda Therapeutics
- Mission: Arda Therapeutics aims to target and eliminate the pathogenic cells that drive chronic diseases and aging. The company focuses on developing innovative therapeutic approaches that start by using single-cell data to identify and target pathogenic cells.
- Founding: No information is available.
- Founders: Dr. Adam Freund, PhD (Founder & Chief Executive Officer)
- Key People:
- Adam Freund, PhD: Founder & Chief Executive Officer with 20 years of experience in life science R&D.
- Scott Turner, PhD: Chief Scientific Officer, a globally recognized leader in drug development with expertise in anti-fibrotic therapies.
- Remi-Martin Laberge, PhD: Co-founder & Chief Technology Officer, experienced in pathogenic cell elimination.
- Headquarters: 930 Brittan Ave, San Carlos, CA 94070
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: Arda Therapeutics is known for adopting a novel approach that focuses on depleting cells that drive diseases rather than modulating protein activity.
Products
- Products Offered: Therapies designed to eliminate pathogenic cells for treating chronic diseases.
- Description:
- Utilizes single-cell data to identify pathogenic cells.
- Designs therapies aimed at eliminating these specific cells.
- Key Features:
- Highly targeted cell depletion strategies.
- Initially focused on immunological and inflammatory diseases.
Recent Developments
- New Products Launched: No information is available.
- New Features Added: No information is available.
- Recent Developments:
- On 10/9/24, Arda Therapeutics secured $43M in Series A Financing to advance targeted cell depletion therapies.
- Arda frequently participates in conferences to present their developments, such as the Antifibrotics Drug Development Conference and IPF Summit.
- Dr. Adam Freund and Dr. Remi-Martin Laberge have featured on podcasts to discuss their research and technological advancements.
- New Partnerships: No information is available.
This report is designed to provide an in-depth and structured overview of Arda Therapeutics based on the available data. For fields where the information was not found, it has been noted that no information is available.
